| Steven P Binette, MD | |
|
471 W Army Trail Rd, Suite 103, Bloomingdale, IL 60108-2673 | |
| (630) 980-3366 | |
| (630) 980-3686 |
| Full Name | Steven P Binette |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 40 Years |
| Location | 471 W Army Trail Rd, Bloomingdale, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770535445 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 036-071458 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dupage Medical Group Ltd | 5496667941 | 1209 |
News Archive
Anti-depressants may help spur the creation and survival of new brain cells after brain injury, according to a study by neurosurgeons at the University of Rochester Medical Center.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has held its second meeting with the Australian Therapeutic Goods Administration ("TGA") to discuss milestones for approval of PV-10 for treatment of metastatic melanoma. The TGA is the part of the Australian Government's Department of Health and Ageing responsible for the assessment, approval and monitoring of therapeutic goods available in Australia. The initial meeting with the TGA was held in October 2008.
USACIG, Inc. and Hop-on, Inc. are proud to announce that USACIG has signed an exclusive agreement with Hop-on, Inc. to submit its Electric Cigarette Nicotine water technology to the FDA for clinical studies for the prevention of Parkinson's disease and for the alleviation of its symptoms.
Seattle Genetics, Inc. today announced that data from its brentuximab vedotin and dacetuzumab programs will be presented at the 11th International Conference on Malignant Lymphoma being held June 15-18, 2011 in Lugano, Switzerland.
In this post on the Center for Global Development's (CGD) "Global Health Policy" blog, CGD's Victoria Fan, Rachel Silverman, and Amanda Glassman examine "the preliminary report on the pilot of PEPFAR's Expenditure Analysis Initiative, an important and exciting move by PEPFAR towards evidence-based decision making and greater transparency."
› Verified 8 days ago
| Entity Name | Dupage Medical Group Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801833983 PECOS PAC ID: 5496667941 Enrollment ID: O20031110000535 |
News Archive
Anti-depressants may help spur the creation and survival of new brain cells after brain injury, according to a study by neurosurgeons at the University of Rochester Medical Center.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has held its second meeting with the Australian Therapeutic Goods Administration ("TGA") to discuss milestones for approval of PV-10 for treatment of metastatic melanoma. The TGA is the part of the Australian Government's Department of Health and Ageing responsible for the assessment, approval and monitoring of therapeutic goods available in Australia. The initial meeting with the TGA was held in October 2008.
USACIG, Inc. and Hop-on, Inc. are proud to announce that USACIG has signed an exclusive agreement with Hop-on, Inc. to submit its Electric Cigarette Nicotine water technology to the FDA for clinical studies for the prevention of Parkinson's disease and for the alleviation of its symptoms.
Seattle Genetics, Inc. today announced that data from its brentuximab vedotin and dacetuzumab programs will be presented at the 11th International Conference on Malignant Lymphoma being held June 15-18, 2011 in Lugano, Switzerland.
In this post on the Center for Global Development's (CGD) "Global Health Policy" blog, CGD's Victoria Fan, Rachel Silverman, and Amanda Glassman examine "the preliminary report on the pilot of PEPFAR's Expenditure Analysis Initiative, an important and exciting move by PEPFAR towards evidence-based decision making and greater transparency."
› Verified 8 days ago
| Entity Name | Dr Paul K. Rosenberg, Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093865339 PECOS PAC ID: 4587647805 Enrollment ID: O20040609000216 |
News Archive
Anti-depressants may help spur the creation and survival of new brain cells after brain injury, according to a study by neurosurgeons at the University of Rochester Medical Center.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has held its second meeting with the Australian Therapeutic Goods Administration ("TGA") to discuss milestones for approval of PV-10 for treatment of metastatic melanoma. The TGA is the part of the Australian Government's Department of Health and Ageing responsible for the assessment, approval and monitoring of therapeutic goods available in Australia. The initial meeting with the TGA was held in October 2008.
USACIG, Inc. and Hop-on, Inc. are proud to announce that USACIG has signed an exclusive agreement with Hop-on, Inc. to submit its Electric Cigarette Nicotine water technology to the FDA for clinical studies for the prevention of Parkinson's disease and for the alleviation of its symptoms.
Seattle Genetics, Inc. today announced that data from its brentuximab vedotin and dacetuzumab programs will be presented at the 11th International Conference on Malignant Lymphoma being held June 15-18, 2011 in Lugano, Switzerland.
In this post on the Center for Global Development's (CGD) "Global Health Policy" blog, CGD's Victoria Fan, Rachel Silverman, and Amanda Glassman examine "the preliminary report on the pilot of PEPFAR's Expenditure Analysis Initiative, an important and exciting move by PEPFAR towards evidence-based decision making and greater transparency."
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven P Binette, MD Po Box 713260, Chicago, IL 60677-1260 Ph: (630) 469-9200 | Steven P Binette, MD 471 W Army Trail Rd, Suite 103, Bloomingdale, IL 60108-2673 Ph: (630) 980-3366 |
News Archive
Anti-depressants may help spur the creation and survival of new brain cells after brain injury, according to a study by neurosurgeons at the University of Rochester Medical Center.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has held its second meeting with the Australian Therapeutic Goods Administration ("TGA") to discuss milestones for approval of PV-10 for treatment of metastatic melanoma. The TGA is the part of the Australian Government's Department of Health and Ageing responsible for the assessment, approval and monitoring of therapeutic goods available in Australia. The initial meeting with the TGA was held in October 2008.
USACIG, Inc. and Hop-on, Inc. are proud to announce that USACIG has signed an exclusive agreement with Hop-on, Inc. to submit its Electric Cigarette Nicotine water technology to the FDA for clinical studies for the prevention of Parkinson's disease and for the alleviation of its symptoms.
Seattle Genetics, Inc. today announced that data from its brentuximab vedotin and dacetuzumab programs will be presented at the 11th International Conference on Malignant Lymphoma being held June 15-18, 2011 in Lugano, Switzerland.
In this post on the Center for Global Development's (CGD) "Global Health Policy" blog, CGD's Victoria Fan, Rachel Silverman, and Amanda Glassman examine "the preliminary report on the pilot of PEPFAR's Expenditure Analysis Initiative, an important and exciting move by PEPFAR towards evidence-based decision making and greater transparency."
› Verified 8 days ago
Dr. Marija N Molnar, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 290 Springfield Dr, Suite 290, Bloomingdale, IL 60108 Phone: 630-582-8600 Fax: 630-582-1369 | |
Reinaldo Sanchez, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 471 W Army Trail Rd Ste 103, Bloomingdale, IL 60108 Phone: 630-980-3366 Fax: 630-980-3686 | |
Meghan Catherine Cox-pedota, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 471 W Army Trail Rd Ste 103, Bloomingdale, IL 60108 Phone: 630-980-3366 | |
Dr. Tiffany Maryoung Rogers, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 471 W. Army Trail Rd, Suite 103, Bloomingdale, IL 60108 Phone: 630-980-3366 | |
Stuart Heimburger, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 471 W Army Trail Rd Ste 103, Bloomingdale, IL 60108 Phone: 630-980-3366 | |
Michelle L Szwedo, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 471 W Army Trail Rd, Suite 103, Bloomingdale, IL 60108 Phone: 630-980-3366 Fax: 630-980-3686 | |
Salvatore Reda, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 231 S Gary Ave, Ste 114, Bloomingdale, IL 60108 Phone: 630-893-8585 |